Abstract
THE damaging effect of aspirin on the gastric mucosa has been well documented by endoscopy1 2 3 4 5 6 and by studies of fecal blood loss.7 , 8 Because of the unquestioned value of aspirin in the therapy of rheumatoid diseases and other painful musculoskeletal disorders, various buffered and enteric-coated aspirin compounds have been developed in an attempt to circumvent this serious problem. Our study had two purposes: to determine by an endoscopic technique in a controlled prospective manner whether buffering or enteric coating was effective in ameliorating this major side effect of aspirin therapy; and to observe concurrently whether the changes seen in the gastric . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
